To continue our investigation, we assessed spatial learning and memory in AD mice, both conditional knock-out for c-Abl in the brain or fed with neurotinib, a recently designed and disclosed allosteric c-Abl inhibitor with improved CNS permeability (Marin et al., 2022), to perform additional hippocampus-dependent tests. The gene discussed is ABL1; the disease is Alzheimer disease.